JPS638940B2 - - Google Patents
Info
- Publication number
- JPS638940B2 JPS638940B2 JP3485079A JP3485079A JPS638940B2 JP S638940 B2 JPS638940 B2 JP S638940B2 JP 3485079 A JP3485079 A JP 3485079A JP 3485079 A JP3485079 A JP 3485079A JP S638940 B2 JPS638940 B2 JP S638940B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- pyridazinone
- skeleton
- bond
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical group OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 claims description 9
- -1 p-bromphenyl group Chemical group 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 150000003556 thioamides Chemical class 0.000 claims description 5
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 3
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- NFXSXVAKSSZBJS-UHFFFAOYSA-N 2-(6-oxo-3-phenylpyridazin-1-yl)ethanethioamide Chemical compound C1=CC(=O)N(CC(=N)S)N=C1C1=CC=CC=C1 NFXSXVAKSSZBJS-UHFFFAOYSA-N 0.000 description 1
- UADWUKXUAKHTKU-UHFFFAOYSA-N 3-(6-oxo-3-thiophen-2-ylpyridazin-1-yl)propanethioamide Chemical compound C1=CC(=O)N(CCC(=N)S)N=C1C1=CC=CS1 UADWUKXUAKHTKU-UHFFFAOYSA-N 0.000 description 1
- ORSUMIZRRGPJBR-UHFFFAOYSA-N 4,5-dihydro-1h-pyridazin-6-one Chemical class O=C1CCC=NN1 ORSUMIZRRGPJBR-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 102100021022 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3485079A JPS55118469A (en) | 1979-03-02 | 1979-03-02 | Thioamide derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3485079A JPS55118469A (en) | 1979-03-02 | 1979-03-02 | Thioamide derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55118469A JPS55118469A (en) | 1980-09-11 |
| JPS638940B2 true JPS638940B2 (enrdf_load_stackoverflow) | 1988-02-25 |
Family
ID=12425649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3485079A Granted JPS55118469A (en) | 1979-03-02 | 1979-03-02 | Thioamide derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55118469A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1209998A (en) * | 1981-03-09 | 1986-08-19 | David J. Gilman | Amide derivatives as histamine h-2 receptor antagonists |
| JPH06763B2 (ja) * | 1984-08-28 | 1994-01-05 | 吉富製薬株式会社 | ベンゾ〔ｈ〕シンノリン誘導体 |
-
1979
- 1979-03-02 JP JP3485079A patent/JPS55118469A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55118469A (en) | 1980-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2129553C1 (ru) | Производные тиазолидиндиона, их получение и фармацевтическая композиция | |
| EP0330242B1 (en) | Pyridazinone derivatives, their preparation and use | |
| JPS5822119B2 (ja) | ジチオ−ル誘導体 | |
| JPH01261381A (ja) | オキサ（チア）ジアゾール誘導体、その製造方法及び殺ダニ剤 | |
| EP0508740B1 (en) | Thiazolidinedione derivatives, their production and their use | |
| KR900003368B1 (ko) | 신규한 인데노티아졸 유도체의 제조방법 | |
| KR910007973B1 (ko) | 크로몬-및 티오크로몬-치환된 1,4-디하이드로피리딘 유도체의 제조방법 | |
| JPS638940B2 (enrdf_load_stackoverflow) | ||
| KR840001614B1 (ko) | 4-치환된 피리딘 및 피리미딘 유도체의 제조방법 | |
| US4297357A (en) | N-Phenethylacetamide compounds and process for preparation thereof | |
| JPS60105672A (ja) | 胃抗分泌剤としてのチアトリアジンジオキサイド類 | |
| US4609659A (en) | 2,6-disubstituted derivatives of 3-nitropyrazines useful as adjuncts to radiation therapy | |
| US4275069A (en) | Anti-diabetic 1,2-dihydro-2-oxo-6-alkyl-nicotinic acids | |
| JPS6094972A (ja) | キナゾリン誘導体、その製法および該化合物を含有する医薬品 | |
| US4261998A (en) | Tetrahydro-isoquinoline derivatives | |
| US4500520A (en) | Antiinflammatory and/or analgesic silylfurans | |
| SU1080743A3 (ru) | Способ получени производных диалуровой кислоты | |
| CA1164862A (en) | Indol acetic derivates, process for producing the same and pharmaceutical compositions comprising the same | |
| JP2667505B2 (ja) | イソオキサゾール類誘導体およびその用途 | |
| US3714182A (en) | Imino-benzyl-pyrazoles | |
| US3290312A (en) | Triamino pteridine compounds | |
| JPH0283372A (ja) | シクロヘキシルイミダゾール誘導体 | |
| DE3726381A1 (de) | Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| KR960016540B1 (ko) | 신규 옥타히드로 인데노푸란 유도체, 그 제조 방법 및 이를 함유한 치료 조성물 | |
| KR970011301B1 (ko) | 신규(아릴 또는 헤테로방향족 메틸)-2,2'-비-1h-이미다졸 |